Hormonal modulation of GM-CSF receptor alpha-chain in in vitro models of endometrial cancer

European Journal of Gynaecological Oncology

Volumn 21, Issue 3, 2000, Pages 305-308

  Baj, G ^a   Arnulfo, A ^a   Boldorini, R ^a   Nicosia, G ^a   Villa, L ^b   Malavasi, F ^b   Surico, N ^a   Yalman, Deniz ^c  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Endometrial cancer; GM CSF receptor; Progesterone

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; PROGESTERONE;

ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CANCER; HORMONAL REGULATION; HUMAN; HUMAN CELL; PATHOGENESIS;

DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENDOMETRIAL NEOPLASMS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MIFEPRISTONE; PROGESTERONE; RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; TUMOR CELLS, CULTURED;

EID: 0033927506     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Marchetti D. L., Caglar H., Driscoll D. L. et al.: "Pelvic radiation in stage I endometrial adenocarcinonia with high-risk attributes". Gynecol. Oncol., 1990, 37 (1), 51.
2. Lurain J. R., Rice B. L., Rademaker A. W. et al.: "Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium". Obstet. Gynecol., 1991, 78 (1), 63.
3. Kadar N., Homesley H. D., Malfetano J. H.: "Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease". Gynecologic Oncology, 1992, 46 (2), 145.
4. Morrow C. P., Bundy B. N., Kurman R. J. et al.: "Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic-Oncology Group study". Gynecologic Oncology, 1991, 40 (1), 55.
5. Grigsby W. P., Perez C. A., Kuten A. et al.: "Clinical stage I endometrial cancer: Results of adjuvant irradiation and patterns of failure". Int. J. Radiat. Oncol. Biol. Phys., 1992, 21, 379.
6. Grigsby W. P., Perez C. A., Kuten A. et al.: "Clinical stage I endometrial cancer: Prognostic factors for local control and distant metastases and implications of the new FIGO surgical staging system". Int. J. Radiat. Oncol. Biol. Phys., 1991, 22, 905.
7. Rouanet P., Dubois J. B.b Gely S. et al.: "Exclusive radiation therapy in endometrial carcinoma". Int. J. Radiat. Oncol. Biol. Phys., 1992, 26, 223.
8. Rush S., Gal D., Potters L. et al.: "Pelvic control following external beam radiation for surgical stage I endometrial adenocarcinoma". Int. J. Radiat. Oncol. Biol. Phys., 1995, 33 (4), 851.
9. Rotman M., Aziz H., Halpern J. et al.: "Endometrial carcinoma: Influence of prognostic factors on radiation management". Cancer, 1993, 71 (4), 1471.
10. rd ed. Philadelphia, Lippincot-Raven Publishers, 1998, 1835.
11. Creasman W. T., Morrow P., Bundy B. N. et al.: "Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group Study". Cancer, 1987, 60, 2035.
12. Salazar O., Feldstein M. L., DePapp E. W. et al.: "The management of clinical stage I endometrial carcinoma". Cancer, 1978, 41, 1016.
13. Eltabbakh G. H., Piver M. S., Hempling R. E. et al.: "Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: Report of a prospective trial". Int. J. Radiat. Oncol. Biol. Phys., 1997, 38, 373.
14. Christopherson W. M., Connely P. J., Alberhasky R. C. et al.: "Carcinoma of the endometrium: an analysis of prognosticators in patients with favorable subtypes and stage I disease". Cancer, 1983, 51, 1705.
15. Cheon H.: "Prognosis of endometrial carcinoma". Obstet. Gynecol., 1989, 34, 680.
16. Thomas H., Pickering D. G. L., Dunn P. et al.: "Treating the vaginal vault in carcinoma of the endometrium using the Buchler afterloading system". British Journal of Radiology, 1991, 64, 1044.
17. Ahmad K., Kim Y. H., Deppe G. et al.: "Radiation therapy in stage II carcinoma of the endometrium". Cancer, 1989, 63, 854.
18. Vaeth J. M., Fontanesi J., Tralins A. H., Chauser B. M.: "External radiation therapy of stage I cancer of the endometrium: a need for reappraisal of this adjunctive modality". Int. J. Radiat. Oncol. Biol. Phys., 1988, 15, 1291.
19. Hanson M. D., Van Nagell J.R., Powell D. E. et al.: "The prognostic significance of lymphvascular space invasion in stage I endometrial cancer". Cancer, 1985, 55, 1753.
20. Heath R,. Roseman J., Varia M., Walton L.: "Peritoneal fluid cytology in endometrial cancer: its significance and the role of chromic phosphate (32P) therapy". Int. J. Radiat. Oncol. Biol. Phys., 1988, 15, 815.
21. Bruckman J. E., Goodman L. E., Murthy A. et al.: "Combined irradiation and surgery in the treatment of stage II carcinoma of the endometrium". Cancer, 1978, 42, 1146.
22. Homesely H. D., Boronow R. C., Lewis J. L. Jr.: "Stage II endometrial adenocarcinoma. Memorial Hospital for Cancer. 1949-1965". Obstet. Gynecol., 1977, 49, 604.
23. Surwit E. A., Fowler W. C. Jr., Rogoff E. E. et al.: "Stage II adenocarcinoma of the endometrium". Int. J. Radiat. Oncol. Biol. Phys., 1979, 5, 323.
24. nd ed. Edinburgh, Churchill Livingstone, 1992, 75.
25. Bedwinek J., Galakatos A., Camel M. et al.: "Stage I, grade III adenocarcinoma of the endometrium treated with surgery and irradiation: Sites of failure and correlation of failure rate with irradiation technique". Cancer, 1984, 54, 40.